Establishment Labs (ESTA) - Net earnings per share (EPS TTM)

Establishment Labs generates revenue through the sale of high-tech Motiva implants and digital services. Its aesthetic medicine clientele values the safety of premium solutions. Strong operating leverage during production scaling effectively increases margins. The company's net income per share over 12 months clearly demonstrates this resilience, with the indicator reaching -1.28.
ESTA (Establishment Labs Corp): analytical breakdowns and indicator data

Portfolio managers evaluate the operating model of Establishment Labs (ESTA) through net earnings per share, which measures the beneficiary's actual annual income after all expenses. By analyzing the trailing 12-month earnings per share, investors can see how the premium status of implants and expansion into aesthetic surgery translate into financial stability and growth in business capitalization.